WallStreetZenWallStreetZen

NASDAQ: PLYX
Polaryx Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Polaryx Therapeutics earnings were -$6.8M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest PLYX earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$1.4M, down 45.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PLYX reported annual earnings of -$9.0M, with -70.4% growth. The next PLYX earnings date is Nov 12, 2026.

PLYX earnings history

Current Revenue
$0.0
Current Earnings
-$6.8M
Current Profit Margin
0%

PLYX Return on Equity

Current Company
-117.6%
Current Industry
-13.6%
Current Market
30.9%
PLYX's Return on Equity (-117.6%)... subscribe to Premium to read more.
High Return on Equity Performance

PLYX Return on Assets

Current Company
-103.5%
Current Industry
-10.3%
PLYX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PLYX announces earnings.

PLYX Return on Capital Employed

Current Company
-62.61%
Current Industry
-7%

PLYX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PLYXN/A-$6.85MN/A-$0.14
SEER-$61.98M-$67.96MN/A-$1.22
CGTX-$16.52M-$16.78MN/A-$0.17
NTRB-$6.76M-$6.96MN/A-$0.53
ONCY-$37.61M-$38.13MN/A-$0.34
View Top Biotech Stocks

PLYX earnings dates

Next earnings date
Nov 12, 2026

Polaryx Therapeutics Earnings Reports & History FAQ

What were Polaryx Therapeutics's earnings last quarter?

On PLYX's earnings call on Aug 13, 2026, Polaryx Therapeutics (NASDAQ: PLYX) reported Q2 2026 earnings per share (EPS) of -$0.03, up 50% year over year. Total PLYX earnings for the quarter were -$1.38 million. In the same quarter last year, Polaryx Therapeutics's earnings per share (EPS) was -$0.02.

If you're new to stock investing, here's how to buy Polaryx Therapeutics stock.

When does Polaryx Therapeutics report earnings?

The next PLYX earnings call is Nov 12, 2026. Add PLYX to your watchlist to be reminded of Polaryx Therapeutics's next earnings date.

Is Polaryx Therapeutics profitable or losing money?

As of the last Polaryx Therapeutics earnings report, Polaryx Therapeutics is currently losing money. Polaryx Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$6.85 million, a 9.33% decrease year over year.

What was PLYX's earnings growth in the past year?

As of Polaryx Therapeutics's earnings date in Aug 13, 2026, Polaryx Therapeutics's earnings has grown year over year. PLYX earnings in the past year totalled -$6.85 million.

What are Polaryx Therapeutics's earnings expectations?

The current EPS estimate for Polaryx Therapeutics's earnings report in Nov 12, 2026 is -$0.06.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.